HSA — authorised 12 August 2020
- Marketing authorisation holder: NIPPON SHINYAKU
- Status: likely_approved
🇸🇬 Viltepso in Singapore
HSA authorised Viltepso on 12 August 2020
Marketing authorisation
Viltepso in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in Singapore
Frequently asked questions
Is Viltepso approved in Singapore?
Yes. HSA authorised it on 12 August 2020.
Who is the marketing authorisation holder for Viltepso in Singapore?
NIPPON SHINYAKU holds the Singaporean marketing authorisation.